380 related articles for article (PubMed ID: 16229372)
1. ["Pathophysiology and treatment of the overactive bladder"].
Yokoyama O
Hinyokika Kiyo; 2005 Sep; 51(9):599-601. PubMed ID: 16229372
[TBL] [Abstract][Full Text] [Related]
2. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
3. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
[TBL] [Abstract][Full Text] [Related]
4. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
[TBL] [Abstract][Full Text] [Related]
5. Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease.
Ransmayr GN; Holliger S; Schletterer K; Heidler H; Deibl M; Poewe W; Madersbacher H; Kiss G
Neurology; 2008 Jan; 70(4):299-303. PubMed ID: 18209204
[TBL] [Abstract][Full Text] [Related]
6. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
Garely AD; Lucente V; Vapnek J; Smith N
Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
[TBL] [Abstract][Full Text] [Related]
7. Dysfunctional voiding in women.
Carlson KV; Rome S; Nitti VW
J Urol; 2001 Jan; 165(1):143-7; discussion 147-8. PubMed ID: 11125384
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic Parkinson's disease patients at the urologic clinic.
Ragab MM; Mohammed ES
Neurourol Urodyn; 2011 Sep; 30(7):1258-61. PubMed ID: 21404318
[TBL] [Abstract][Full Text] [Related]
9. Overactive bladder symptoms: do we need urodynamics?
Digesu GA; Khullar V; Cardozo L; Salvatore S
Neurourol Urodyn; 2003; 22(2):105-8. PubMed ID: 12579626
[TBL] [Abstract][Full Text] [Related]
10. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
Bach P; Wormland RT; Möhring C; Goepel M
Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067
[TBL] [Abstract][Full Text] [Related]
11. Urgency is the core symptom of female overactive bladder syndrome, as demonstrated by a statistical analysis.
Hung MJ; Ho ES; Shen PS; Sun MJ; Lin AT; Chen GD;
J Urol; 2006 Aug; 176(2):636-40. PubMed ID: 16813910
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction.
Seki N; Yuki K; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2009; 28(3):197-201. PubMed ID: 18973143
[TBL] [Abstract][Full Text] [Related]
13. Overactive bladder--a practical approach to evaluation and management.
Madersbacher H
J Med Liban; 2004; 52(4):220-6. PubMed ID: 16432986
[TBL] [Abstract][Full Text] [Related]
14. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom.
Kim JC; Park EY; Hong SH; Seo SI; Park YH; Hwang TK
Int J Urol; 2005 Oct; 12(10):875-80. PubMed ID: 16323980
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of overactive bladder.
Milsom I; Stewart W; Thüroff J
Am J Manag Care; 2000 Jul; 6(11 Suppl):S565-73. PubMed ID: 11183899
[TBL] [Abstract][Full Text] [Related]
16. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
[TBL] [Abstract][Full Text] [Related]
17. [Overactive bladder in female and new strategy].
Kubota Y; Sasaki S; Kojima Y; Hayase M; Kohri K
Hinyokika Kiyo; 2007 Jun; 53(6):435-9. PubMed ID: 17628947
[TBL] [Abstract][Full Text] [Related]
18. What is the effect of overactive bladder symptoms on woman's quality of life during and after first pregnancy?
Van Brummen HJ; Bruinse HW; Van de Pol G; Heintz AP; Van der Vaart CH
BJU Int; 2006 Feb; 97(2):296-300. PubMed ID: 16430633
[TBL] [Abstract][Full Text] [Related]
19. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
20. Redefining response in overactive bladder syndrome.
Payne CK; Kelleher C
BJU Int; 2007 Jan; 99(1):101-6. PubMed ID: 17227496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
